![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GSK Plc (PK) | USOTC:GLAXF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.665 | -3.21% | 20.06 | 19.78 | 21.77 | 20.06 | 20.06 | 20.06 | 1,094 | 21:18:01 |
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Emma Walmsley
|
|||
b)
|
Position/status
|
Chief Executive Officer
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Julie Brown
|
|||
b)
|
Position/status
|
Chief Financial Officer
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
James Ford
|
|||
b)
|
Position/status
|
SVP and Group General Counsel, Legal and Compliance
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Sally Jackson
|
|||
b)
|
Position/status
|
SVP, Global Communications and CEO Office
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
David Redfern
|
|||
b)
|
Position/status
|
President, Corporate Development
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Regis Simard
|
|||
b)
|
Position/status
|
President, Global Supply Chain
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Philip Thomson
|
|||
b)
|
Position/status
|
President, Global Affairs
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Deborah Waterhouse
|
|||
b)
|
Position/status
|
CEO, ViiV Healthcare and President, Global Health, GSK
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||||
a)
|
Name
|
Victoria Whyte
|
|||
b)
|
Position/status
|
Company Secretary
|
|||
c)
|
Initial notification/ amendment
|
Initial notification
|
|||
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
GSK plc
|
|||
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|||
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary
Shares')
ISIN: GB00BN7SWP63
|
|||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares under the Company's Share Reward
Plan
|
|||
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
£15.5067
|
8 (partnership shares)
|
|
||
|
£15.5067
|
8 (matching shares)
|
|
||
|
|
|
|
||
d)
|
Aggregated information
|
|
|||
Aggregated volume
Price
|
16 Ordinary Shares
£15.5067
|
||||
e)
|
Date of the transaction
|
2024-08-09
|
|||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
|
GSK plc
|
|
(Registrant)
|
|
|
Date: August
12, 2024
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GSK plc
|
1 Year GSK (PK) Chart |
1 Month GSK (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions